Effect of an artificial intelligence-based quality improvement system on efficacy of a computer-aided detection system in colonoscopy: a four-group parallel study

Liwen Yao, Lihui Zhang, Jun Liu, Wei Zhou, Chunping He, Jun Zhang, Lianlian Wu, Hongguang Wang, Youming Xu, Dexin Gong, Ming Xu, Xun Li, Yutong Bai, Rongrong Gong, Prateek Sharma, Honggang Yu, Liwen Yao, Lihui Zhang, Jun Liu, Wei Zhou, Chunping He, Jun Zhang, Lianlian Wu, Hongguang Wang, Youming Xu, Dexin Gong, Ming Xu, Xun Li, Yutong Bai, Rongrong Gong, Prateek Sharma, Honggang Yu

Abstract

Background: Tandem colonoscopy studies have found that about one in five adenomas are missed at colonoscopy. It remains debatable whether the combination of a computer-aided polyp detection (CADe) system with a computer-aided quality improvement (CAQ) system for real-time monitoring of withdrawal speed results in additional benefits in adenoma detection or if the synergetic effect may be harmed due to excessive visual burden resulting from information overload. This study aimed to evaluate the interaction effect on improving the adenoma detection rate (ADR).

Methods: This single-center, randomized, four-group, parallel, controlled study was performed at Renmin Hospital of Wuhan University. Between 1 July and 15 October 2020, 1076 patients were randomly allocated into four treatment groups: control 271, CADe 268, CAQ 269, and CADe plus CAQ (COMBO) 268. The primary outcome was ADR.

Results: The ADR in the control, CADe, CAQ, and COMBO groups was 14.76 % (95 % confidence interval [CI] 10.54 to 18.98), 21.27 % (95 %CI 16.37 to 26.17), 24.54 % (95 %CI 19.39 to 29.68), and 30.60 % (95 %CI 25.08 to 36.11), respectively. The ADR was higher in the COMBO group compared with the CADe group (21.27 % vs. 30.6 %, P = 0.024, odds ratio [OR] 1.284, 95 %CI 1.033 to 1.596) but not compared with the CAQ group (24.54 % vs. 30.6 %, P = 0.213, OR 1.309, 95 %CI 0.857 to 2.000, respectively).

Conclusions: CAQ significantly improved the efficacy of CADe in a four-group, parallel, controlled study. No significant difference in the ADR or polyp detection rate was found between CAQ and COMBO.

Trial registration: ClinicalTrials.gov NCT04453956.

Conflict of interest statement

The authors declare that they have no conflict of interest.

Thieme. All rights reserved.

Source: PubMed

3
Iratkozz fel